Refractory aphthous ulceration treated with thalidomide: A report of 10 years' clinical experience

Clinical and Experimental Dermatology

Volumn 37, Issue 2, 2012, Pages 132-135

  Cheng, S ^a   Murphy, R ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; STEROID; THALIDOMIDE;

ADOLESCENT; ADULT; APHTHOUS ULCER; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MALE; NEUROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; THROMBOEMBOLISM;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; STOMATITIS, APHTHOUS; THALIDOMIDE;

EID: 84857369166     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04169.x     Document Type: Article

References (10)

1. Rosenbach M, Werth V. Dermatologic therapeutics: thalidomide. A practical guide. Dermatol Ther 2007; 20: 175-86. (Pubitemid 350029308)
2. Wu JJ, Huang DB, Pang KR, et al. Thalidomide: dermatological indications, mechanisms of actions and side-effects. Br J Dermatol 2005; 153: 254-73. (Pubitemid 41228421)
3. De Wazières B, Gil H, Magy N, et al. Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients. Rev Med Interne 1999; 20: 567-70.
4. Hamza MH. Treatment of Behçet's disease with thalidomide. Clin Rheumatol 1986; 5: 365-71.
5. Gardner-Medwin JM, Smith NJ, Powell RH. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994; 53: 828-32.
6. Hamuryudan V, Mat C, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome: a randomised, double-blind, placebo-controlled trial. Ann Intern Med 1998; 128: 443-50.
7. Ranselaar CG, Boone RM, Kluin-Nelemans HC. Thalidomide in the treatment of neuro-Behçet's syndrome. Br J Dermatol 1986; 115: 367-70.
8. Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990; 126: 923-7. (Pubitemid 20224550)
9. Bastuji-Garin S, Ochonisky S, Bouche P, et al. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol 2002; 119: 1020-6. (Pubitemid 35430479)
10. Crawford CL. Use of thalidomide in leprosy. Adverse Drug React Toxicol Rev 1994; 13: 177-92.